http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040093155-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2003-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040093155-A |
| titleOfInvention | Powdery medicinal compositions for inhalation and process for producing the same |
| abstract | The present invention is made up of a physiologically active substance in a crystalline state and a biocompatible electrostatic agglutination inhibitor, and can provide a powder pharmaceutical composition for inhalation which is excellent in safety and stability and has achieved excellent intrapulmonary delivery by a simple method. It is a remarkable effect at one point. In addition, by further selecting a hydrophobic material, it is possible to impart sustained release according to the characteristics of the bioactive material. |
| priorityDate | 2002-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.